Peptide ProvidersDirect

Trust center

Accessibility statement

Our goal is an inclusive research experience that supports keyboard, screen-reader, zoom, contrast, and reduced-motion needs.

Current approach

The interface uses semantic headings, labeled fields, keyboard-operable controls, visible focus states, responsive layouts, and restrained motion. Automated checks complement—but do not replace—manual testing with assistive technology.

Feedback

An accessible feedback channel and response target will be published before launch. Known barriers will be logged, prioritized, and tracked through remediation.

Last operational review: July 15, 2026. Contact information will be added before public launch.